标题
Immune Interventions to Preserve β Cell Function in Type 1 Diabetes
作者
关键词
-
出版物
JOURNAL OF INVESTIGATIVE MEDICINE
Volume -, Issue -, Pages 1
出版商
BMJ
发表日期
2015-10-16
DOI
10.1097/jim.0000000000000227
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Skewing dendritic cell differentiation towards a tolerogenic state for recovery of tolerance in rheumatoid arthritis
- (2015) Katina Schinnerling et al. AUTOIMMUNITY REVIEWS
- Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients
- (2015) Michelle Rosenzwajg et al. JOURNAL OF AUTOIMMUNITY
- Therapy of type 1 diabetes with CD4+CD25highCD127-regulatory T cells prolongs survival of pancreatic islets — Results of one year follow-up
- (2014) Natalia Marek-Trzonkowska et al. CLINICAL IMMUNOLOGY
- β-Cell–Specific CD8 T Cell Phenotype in Type 1 Diabetes Reflects Chronic Autoantigen Exposure
- (2014) Ania Skowera et al. DIABETES
- Reduction in CD4 Central Memory T-Cell Subset in Costimulation Modulator Abatacept-Treated Patients With Recent-Onset Type 1 Diabetes Is Associated With Slower C-Peptide Decline
- (2014) T. Orban et al. DIABETES
- Low-Dose Otelixizumab Anti-CD3 Monoclonal Antibody DEFEND-1 Study: Results of the Randomized Phase III Study in Recent-Onset Human Type 1 Diabetes
- (2014) Ronnie Aronson et al. DIABETES CARE
- Restoring the balance: immunotherapeutic combinations for autoimmune disease
- (2014) D. E. Smilek et al. Disease Models & Mechanisms
- Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009
- (2014) Dana Dabelea et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes
- (2014) Michael J. Haller et al. JOURNAL OF CLINICAL INVESTIGATION
- The Effector T Cells of Diabetic Subjects Are Resistant to Regulation via CD4+FOXP3+ Regulatory T Cells
- (2014) A. Schneider et al. JOURNAL OF IMMUNOLOGY
- Immunology: A tolerant approach
- (2014) Ken Garber NATURE
- Glycemic Control and Excess Mortality in Type 1 Diabetes
- (2014) Marcus Lind et al. NEW ENGLAND JOURNAL OF MEDICINE
- Co-Inhibitory Pathways and Their Importance in Immune Regulation
- (2014) Naoka Murakami et al. TRANSPLANTATION
- Targeted immune interventions for type 1 diabetes
- (2014) Mark R. Rigby et al. Current Opinion in Endocrinology Diabetes and Obesity
- Anti-cytokine therapies in T1D: Concepts and strategies
- (2013) Gerald T. Nepom et al. CLINICAL IMMUNOLOGY
- Trials in type 1 diabetes: Antigen-specific therapies
- (2013) Ken T. Coppieters et al. CLINICAL IMMUNOLOGY
- T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment
- (2013) Joel Crespo et al. CURRENT OPINION IN IMMUNOLOGY
- It's Time to Bring Dendritic Cell Therapy to Type 1 Diabetes
- (2013) R. J. Creusot et al. DIABETES
- Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial: Metabolic and Immunologic Features at Baseline Identify a Subgroup of Responders
- (2013) K. C. Herold et al. DIABETES
- B-Lymphocyte Depletion With Rituximab and -Cell Function: Two-Year Results
- (2013) M. D. Pescovitz et al. DIABETES CARE
- A review of artificial pancreas technologies with an emphasis on bi-hormonal therapy
- (2013) P. A. Bakhtiani et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of low-dose otelixizumab anti-CD3 monoclonal antibody in preserving C-peptide secretion in adolescent type 1 diabetes: DEFEND-2, a randomized, placebo-controlled, double-blind, multi-centre study
- (2013) P. Ambery et al. DIABETIC MEDICINE
- Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes
- (2013) Jing Lu Kroll et al. JOURNAL OF CLINICAL VIROLOGY
- Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
- (2013) Antoinette Moran et al. LANCET
- TNF-α trips up Treg cells in rheumatoid arthritis
- (2013) Jonathan Bromberg NATURE MEDICINE
- Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis
- (2013) Noriko Komatsu et al. NATURE MEDICINE
- Targeting co-stimulatory pathways: transplantation and autoimmunity
- (2013) Mandy L. Ford et al. Nature Reviews Nephrology
- Transient B-Cell Depletion with Anti-CD20 in Combination with Proinsulin DNA Vaccine or Oral Insulin: Immunologic Effects and Efficacy in NOD Mice
- (2013) Ghanashyam Sarikonda et al. PLoS One
- Plasmid-Encoded Proinsulin Preserves C-Peptide While Specifically Reducing Proinsulin-Specific CD8+ T Cells in Type 1 Diabetes
- (2013) B. O. Roep et al. Science Translational Medicine
- Regulatory T-Cell Therapy in Transplantation: Moving to the Clinic
- (2013) Q. Tang et al. Cold Spring Harbor Perspectives in Medicine
- Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial
- (2013) Mark R Rigby et al. Lancet Diabetes & Endocrinology
- Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
- (2013) Agnès Hartemann et al. Lancet Diabetes & Endocrinology
- Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial
- (2013) Stephen E Gitelman et al. Lancet Diabetes & Endocrinology
- Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs -Cell Function
- (2012) S. A. Long et al. DIABETES
- Administration of CD4+CD25highCD127- Regulatory T Cells Preserves -Cell Function in Type 1 Diabetes in Children
- (2012) N. Marek-Trzonkowska et al. DIABETES CARE
- Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial
- (2012) K. C. Herold et al. DIABETOLOGIA
- Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis
- (2011) David B. Clifford ARCHIVES OF NEUROLOGY
- Immunology in the clinic review series: focus on type 1 diabetes and viruses: the role of viruses in type 1 diabetes: a difficult dilemma
- (2011) K. T. Coppieters et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Phase I (Safety) Study of Autologous Tolerogenic Dendritic Cells in Type 1 Diabetic Patients
- (2011) N. Giannoukakis et al. DIABETES CARE
- Anti-CD3 Therapy Promotes Tolerance by Selectively Depleting Pathogenic Cells while Preserving Regulatory T Cells
- (2011) C. Penaranda et al. JOURNAL OF IMMUNOLOGY
- Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial
- (2011) Nicole Sherry et al. LANCET
- Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
- (2011) Tihamer Orban et al. LANCET
- Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group
- (2010) J. B. Matthews et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
- (2010) M. Peakman et al. DIABETES
- Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass
- (2010) B. Keymeulen et al. DIABETOLOGIA
- Acquisition of regulatory function by human CD8+ T cells treated with anti-CD3 antibody requires TNF
- (2010) Vitaly Ablamunits et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Etiology of Type 1 Diabetes
- (2010) John A. Todd IMMUNITY
- Genetics, pathogenesis and clinical interventions in type 1 diabetes
- (2010) Jeffrey A. Bluestone et al. NATURE
- Etanercept Treatment in Children With New-Onset Type 1 Diabetes: Pilot randomized, placebo-controlled, double-blind study
- (2009) L. Mastrandrea et al. DIABETES CARE
- Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study
- (2009) Christopher C Patterson et al. LANCET
- Regulatory T cells exert checks and balances on self tolerance and autoimmunity
- (2009) Kajsa Wing et al. NATURE IMMUNOLOGY
- Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
- (2009) Mark D. Pescovitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expansion of Human Regulatory T-Cells From Patients With Type 1 Diabetes
- (2008) A. L. Putnam et al. DIABETES
- Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways
- (2008) Brian T. Fife et al. IMMUNOLOGICAL REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started